Blog

New Draft Guidance on Gene Therapy

On July 11, 2018 the US Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER) offered 6 new draft guidance documents on human gene therapies. The documents offer a look at what it expects from an industry that is becoming...

read more

Pearl Pathways to exhibit at DIA 2018 in Boston

Join us at the DIA 2018 Global Annual Meeting in Boston from June 24-28. Gretchen Bowker, Chad Pannucci, Nancy Kant and Waylon Wright will all be in attendance from Pearl.  Learn more about regulatory challenges, industry trends, evolving clinical research...

read more